Tumor growth inhibitionEnhanced proportion of CD8+ T cellsReduced proportion of regulatory cells (CD25+ Foxp3+ T cells) in the spleenDisruption of mitochondrial activityPromotion of oxidative stressRelief of immune suppression. The gene discussed is CD8A; the disease is neoplasm.